Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P51
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -21.13% |
| Q3 2025 | -36.09% |
| Q2 2025 | -13.62% |
| Q1 2025 | -47.49% |
| Q4 2024 | -11.53% |
| Q3 2024 | -85.80% |
| Q2 2024 | 473.82% |
| Q1 2024 | 166.69% |
| Q4 2023 | 39.92% |
| Q3 2023 | -2747.24% |
| Q2 2023 | -106.37% |
| Q1 2023 | -36.44% |
| Q4 2022 | -50.90% |
| Q3 2022 | -36.86% |
| Q2 2022 | -25.78% |
| Q1 2022 | -17.66% |
| Q4 2021 | -16.09% |
| Q3 2021 | -22.68% |
| Q2 2021 | -19.38% |
| Q1 2021 | -14.25% |
| Q4 2020 | 95.67% |
| Q3 2020 | -57.47% |
| Q2 2020 | 159.33% |
| Q1 2020 | -42.11% |
| Q4 2019 | -25.93% |
| Q3 2019 | -43.24% |
| Q2 2019 | 11.28% |
| Q1 2019 | -26.38% |
| Q4 2018 | -47.13% |
| Q3 2018 | 94.95% |
| Q2 2018 | -38.69% |
| Q1 2018 | -32.97% |
| Q4 2017 | 17.36% |
| Q3 2017 | -30.16% |
| Q2 2017 | 2015.12% |
| Q1 2017 | -12.34% |
| Q4 2016 | -9.15% |
| Q3 2016 | -36.70% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |